What the FDA labels say about taking them together
Atropine and sugammadex
Sugammadex's FDA label of March 13, 2026 names atropine in its warnings and precautions section; the atropine labels PlainMeds reads (4) do not name sugammadex. The sugammadex label: “Monitor for hemodynamic changes and administer anticholinergic agents such as atropine if clinically significant bradycardia is observed.”
Check it at the source: the atropine FDA label on DailyMed (effective May 18, 2026, Hospira, Inc.); the sugammadex FDA label on DailyMed (effective March 13, 2026, Merck Sharp & Dohme LLC).
What does the atropine label say about sugammadex?
Atropine's label (effective May 18, 2026) and its 3 other brand-application labels do not name sugammadex in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Atropine Sulfate), Hospira, Inc., effective May 18, 2026 (SPL set ad8916e7-206e-409e-2582-30d072845dd4), via openFDA; the full label on DailyMed
What does the sugammadex label say about atropine?
Sugammadex label, warnings and precautionsMonitor for hemodynamic changes and administer anticholinergic agents such as atropine if clinically significant bradycardia is observed.
Source: FDA drug label (BRIDION), Merck Sharp & Dohme LLC, effective March 13, 2026 (SPL set 5171d883-fe8f-482c-97ab-40b00975b64a), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Atropine | Sugammadex | |
|---|---|---|
| Labeled for | n/a | n/a |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | $7.74 per mL 1% eye drops | n/a |
| Shortage now | In shortage | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once